VOYA Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-193,083
Closed -$220K 2936
2022
Q1
$220K Buy
193,083
+152,535
+376% +$182K ﹤0.01% 2318
2021
Q4
$92K Buy
40,548
+5,502
+16% +$13.8K ﹤0.01% 2674
2021
Q3
$120K Hold
35,046
﹤0.01% 2701
2021
Q2
$105K Buy
+35,046
New +$111K ﹤0.01% 2764
2017
Q2
Sell
-24,497
Closed -$79K 2660
2017
Q1
$79K Hold
24,497
﹤0.01% 2453
2016
Q4
$33K Hold
24,497
﹤0.01% 2516
2016
Q3
$38 Hold
24,497
﹤0.01% 2528
2016
Q2
$33K Hold
24,497
﹤0.01% 2552
2016
Q1
$129K Hold
24,497
﹤0.01% 2347
2015
Q4
$192K Hold
24,497
﹤0.01% 2296
2015
Q3
$207K Sell
24,497
-6,383
-21% -$58.9K ﹤0.01% 2255
2015
Q2
$338K Sell
30,880
-2,750
-8% -$35.3K ﹤0.01% 2182
2015
Q1
$470K Hold
33,630
﹤0.01% 1958
2014
Q4
$568K Hold
33,630
﹤0.01% 1851
2014
Q3
$451K Hold
33,630
﹤0.01% 1981
2014
Q2
$428K Hold
33,630
﹤0.01% 2099
2014
Q1
$400K Hold
33,630
﹤0.01% 2134
2013
Q4
$464K Buy
33,630
+4,912
+17% +$69.4K ﹤0.01% 2022
2013
Q3
$501K Hold
28,718
﹤0.01% 1906
2013
Q2
$467K Buy
+28,718
New +$889K ﹤0.01% 1892

Other funds holding INFI

VOYA Investment Management's INFI Position: Q2 2022 in Review

VOYA Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 193,083 shares — an estimated $220K sold.

VOYA Investment Management first reported a position in INFI in Q2 2013 and held it in 20 quarters. The position peaked at $568K in Q4 2014. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • VOYA Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 193,083 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $220K.
  • VOYA Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • VOYA Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $568K in Q4 2014.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.